The U.S. Food and Drug Administration (FDA) launched a first-of-its-kind pilot program to collect publicly available information describing consumer-reported symptoms and side effects from cancer trials for marketed treatments. The pilot launched on June 23, 2020, with a new website called Project Patient Voice. The pilot is an initiative of the FDA’s Oncology Center of Excellence. AstraZeneca is the first company to provide consumer-reported outcomes data for one of its FDA-approved drugs, and has collaborated with the FDA to identify methods to display the information in a way intended to be informative . . .
News Report |